Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
Expert consensus on practical aspects in the treatment of chronic urticaria
|Filename||419. Bauer et al., Expert cons. chronic urticaria, AllergoJInt2021.pdf|
|Date added||May 31, 2021|
|Tags||diagnostics, H1-antihistamines, omalizumab, therapy, Treatment recommendations|
|Authors||Bauer, A., Dickel, H., Jakob, T., Kleinheinz, A., Lippert, U., Metz, M., Schliemann, S., Schwichtenberg, U., Staubach, P., Valesky, E., Wagner, N., Wedi, B., and Maurer, M.|
|Citation||Bauer, A., Dickel, H., Jakob, T., Kleinheinz, A., Lippert, U., Metz, M., Schliemann, S., Schwichtenberg, U., Staubach, P., Valesky, E., Wagner, N., Wedi, B., and Maurer, M.: Expert consensus on practical aspects in the treatment of chronic urticaria. Allergo J. Int. 2021. 30; 64-75.|
|Publisher||Allergo J. Int.|
|Corresponding authors||Maurer, M.|
Background Chronic urticaria (CU) is a common disease which represents a considerable burden formany patients. The current urticaria guideline describes the evidence-based diagnosis and treatment of CU. In addition, however, questions often arise in everyday practice that are not addressed by the guideline.
Methods In May 2020, a digital meeting with German urticaria experts was held, in which practical aspects of CU treatment were discussed and supporting aids for everyday clinical treatment formulated. The resulting advice in this document focus on practical questions and the available literature and experiences of the participants.
Results The diagnosis of CU can be made in a short time by means of a thorough anamnesis, a physical examination, and a basic laboratory chemical diagnosis. For this purpose, practical recommendations for everyday practice are given in this paper. An extended diagnosis is only indicated in a few cases and should always be carried out in parallel with an effective therapy. In general, CU should always be treated in the same way, regardless of whether wheals, angioedema or both occur. Symptomatic therapy should be carried out according to the treatment steps recommended by the guidelines. This publication provides practical advice on issues in everyday practice, such as the procedure in the current coronavirus disease 2019 (COVID-19) pandemic, the cardiac risk under higher dosed H1 antihistamines, the self-administration of omalizumab as well as vaccination under omalizumab therapy. In addition to treatment recommendations, topics such as documentation in the practice and family planning with urticaria will be discussed.
Discussion These supporting treatment recommendations serve as an addendum to the current CU guideline and provide support in dealing with CU patients in everyday practice. The aim is to ensure that patients suffering from CU achieve complete freedom of symptoms with the help of an optimal therapy.
(Last update: 08.2021)
|Number of publications (original work and reviews) in peer-reviewed journals:||636|
|Number of original publications in peer-reviewed journals:||462|
|Number of reviews in peer-reviewed journals:||174|
|Cumulative IF of publications (original work & reviews) in peer-reviewed journals:||3834,12|
|Cumulative IF for original publications in peer-reviewed journals:||3043,14|
|Cumulative IF for reviews in peer-reviewed journals:||790,98|
|Citations, Hirsch index: (view on Web of Science)||26429|